New migraine combo drug trial pulled before it started
NCT ID NCT05685225
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 25 times
Summary
This study aimed to test a new combination of naltrexone and acetaminophen for treating migraine attacks. It was designed for adults with migraine who would treat one attack per stage. The trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Keystone Clinical Research
North Miami, Florida, 33181, United States
Conditions
Explore the condition pages connected to this study.